Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells

Background: Treatment of large bone defects due to trauma, tumor resection, or congenital abnormalities is challenging. Bone tissue engineering using mesenchymal stem cells (MSCs) represents a promising treatment option. However, the quantity and quality of engineered bone tissue are not sufficient...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Groeneveldt, Lisanne C., Knuth, Callie, Witte-Bouma, Janneke, O’Brien, Fergal J., Wolvius, Eppo B., Farrell, Eric
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2014
Предметы:
Bioengineering and Biotechnology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4151337/
https://ncbi.nlm.nih.gov/pubmed/25229057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2014.00029
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы